Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FDJR5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,790
Award facts
- Contract value 100% obligated
- $49,790.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $49,790 to DMS Pharmaceutical Group Inc. for FASENRA Pen 30 mg/mL, a biologic pharmaceutical product. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating competitive capability in unrestricted federal procurement. The delivery order was awarded on January 29, 2026, with an ultimate completion date of January 30, 2026, and represents the place of performance as Park Ridge, Illinois.
This delivery order was issued under DMS Pharmaceutical Group's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract, a cornerstone procurement vehicle of the Defense Logistics Agency's broader $30.3 billion pharmaceutical supply initiative. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FDJR5?
SPE2DR26FDJR5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FDJR5 worth?
The government has obligated $49,790 on SPE2DR26FDJR5.
Is contract SPE2DR26FDJR5 an order under another contract?
Yes. SPE2DR26FDJR5 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJR5 competed?
The extent of competition for SPE2DR26FDJR5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award